Suchergebnisse - "Rizvi, Hira"

PubPharm (5)

1

Genomic Landscapes and Hallmarks of Mutant RAS in Human Cancers

enthalten in: Cancer research | 2022

von Scharpf, R. | Balan, A. | Ricciuti, B. | +21

2

Diminished Efficacy of Programmed Death-(Ligand)1 Inhibition in STK11- and KEAP1-Mutant Lung Adenocarcinoma Is Affected by KRAS Mutation Status

enthalten in: Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer | 2022

von Ricciuti, B. | Arbour, K. | Lin, J. | +30

CommentIn: J Thorac Oncol. 2022 Mar;17(3):351-352. - PMID 35216730

3

Treatment Outcomes and Clinical Characteristics of Patients with KRAS-G12C-Mutant Non-Small Cell Lung Cancer

enthalten in: Clinical cancer research : an official journal of the American Association for Cancer Research | 2021

von Arbour, K. | Rizvi, H. | Plodkowski, A. | +10

4

The Genomic Landscape of SMARCA4 Alterations and Associations with Outcomes in Patients with Lung Cancer

enthalten in: Clinical cancer research : an official journal of the American Association for Cancer Research | 2020

von Schoenfeld, A. | Bandlamudi, C. | Lavery, J. | +20

5

STK11/LKB1 Mutations and PD-1 Inhibitor Resistance in KRAS-Mutant Lung Adenocarcinoma

enthalten in: Cancer discovery | 2018

von Skoulidis, F. | Goldberg, M. | Greenawalt, D. | +66

CommentIn: Cancer Discov. 2018 Jul;8(7):794-796. - PMID 29967073

1
[1]